Evidence map›Paper›PMID 39304664›Full record

ArticleNature reviews. Disease primers2024

Publisher Correction: Hazardous drinking and alcohol use disorders.

James MacKillop, Roberta Agabio, Sarah W Feldstein Ewing, Markus Heilig, John F Kelly, Lorenzo Leggio, Anne Lingford-Hughes, Abraham A Palmer, Charles D Parry, Lara Ray and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Disease primers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

James MacKillopPeter Boris Centre for Addictions Research, McMaster University & St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada. jmackill@mcmaster.ca.ORCID http://orcid.org/0000-0002-8695-1071
Roberta AgabioDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.ORCID http://orcid.org/0000-0001-7395-6845
Sarah W Feldstein EwingDepartment of Psychology, University of Rhode Island, Kingston, RI, USA.
Markus HeiligCenter for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
John F KellyRecovery Research Institute and Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Lorenzo LeggioClinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Anne Lingford-HughesDivision of Psychiatry, Imperial College London, London, UK.
Abraham A PalmerDepartment of Psychiatry & Institute for Genomic Medicine, University of California San Diego, La Jolla, CA, USA.
Charles D ParryAlcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Lara RayDepartments of Psychology and Psychiatry, University of California, Los Angeles, Los Angeles, CA, USA.
Jürgen RehmInstitute for Mental Health Policy Research, Campbell Family Mental Health Research Institute, PAHO/WHO Collaborating Centre, Centre for Addiction and Mental Health, Toronto, Canada.ORCID http://orcid.org/0000-0001-5665-0385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39304664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.